Get Pharmaceutical Nanotechnology PDF
By McCarron P.A., Hall M.
Read or Download Pharmaceutical Nanotechnology PDF
Best pharmacology books
Now in its 3rd version, High-Yield™ Pharmacology presents a succinct evaluation of pharmacology whereas clarifying tricky techniques. Need-to-know details is gifted in a transparent, concise define layout. extra positive aspects comprise up-to-date drug references, a drug index, key issues in daring, and tables summarizing key evidence.
This specified quantity explores in silico equipment for pharmaceutical toxicity via combining the theoretical complex study with the sensible software of the instruments. starting with a bit protecting refined versions addressing the binding to receptors, pharmacokinetics and adsorption, metabolism, distribution, and excretion, the publication keeps with chapters delving into versions for particular toxicological and ecotoxicological endpoints, in addition to large perspectives of the most projects and new views that allows you to in all likelihood increase our manner of modelling prescription drugs.
- Bipolar Medications: Mechanisms of Action
- Clinical trials in psychopharmacology : a better brain
- Pharmacology of the Coronary Circulation. Volume 10
- Pharmacology of Cardiac Function. Section of Pharmacology of the International Union of Physiological Sciences
Additional resources for Pharmaceutical Nanotechnology
J. Psychiatry, 162, 2022–2030. REFERENCES 41 Schwab, R. S. and England, A. C. (1969). Third Symposium on Parkinson’s Disease, Royal College of Surgeons in Edinburgh, May 20–22, 1968, pp 152–157. E. & S. Livingstone Ltd. 1969. , Banzato, C. E. , Barasnevicius Quagliato, E. M. A. and Viana, M. A. (2008). Depression in patients with Parkinson’s disease: impact on functioning. J. Neurolog. , 272, 158–163. , Keshavan, M. S. and Nasrallah, H. A. (2008). Schizophrenia, ‘Just the Facts’: What we know in 2008.
Goodwin, G. (2002). Hypomania: what’s in a name? Br. J. Psychiatry, 181, 94–95. Hamilton, M. (1959). The assessment of anxiety states by rating. Br. J. Med. , 32, 50–55. Hamilton, M. (1960). A rating scale for depression. J. Neurol. Neurosurg. Psychiatry, 23, 56–62. Hardy, J. (2006). A hundred years of Alzheimer’s disease research. Neuron, 52, 3–13. Healy, D. (2008). Mania: A short history of bipolar disorder. The Johns Hopkins University Press, Baltimore MD. Herz, J. (2007). Overview: the long and winding road to understanding Alzheimer’s disease.
Tanner, C. M. and Goldman, S. M. (1996). Epidemiology of Parkinson’s disease. Neurol. , 14, 317–335. Weiner, W. J. (2005). A differential diagnosis of Parkinsonism. Rev. Neurol. , 2, 124–131. WHO. (1993). The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. World Health Organization, Geneva. Young, R. , Biggs, J. , Ziegler, V. E. and Meyer, D. A. (1978). A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry, 133, 429–435. Zigmond, A.
Pharmaceutical Nanotechnology by McCarron P.A., Hall M.